PL2183599T3 - Wysoko specyficzny test immunologiczny i zestaw do oznaczania peptydów i białek o znaczeniu biologicznym - Google Patents

Wysoko specyficzny test immunologiczny i zestaw do oznaczania peptydów i białek o znaczeniu biologicznym

Info

Publication number
PL2183599T3
PL2183599T3 PL07847829T PL07847829T PL2183599T3 PL 2183599 T3 PL2183599 T3 PL 2183599T3 PL 07847829 T PL07847829 T PL 07847829T PL 07847829 T PL07847829 T PL 07847829T PL 2183599 T3 PL2183599 T3 PL 2183599T3
Authority
PL
Poland
Prior art keywords
immunoassays
kits
peptides
proteins
determination
Prior art date
Application number
PL07847829T
Other languages
English (en)
Inventor
Barrio J Manuel Sarasa
Original Assignee
Araclon Biotech Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38544110&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2183599(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Araclon Biotech Sl filed Critical Araclon Biotech Sl
Publication of PL2183599T3 publication Critical patent/PL2183599T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL07847829T 2007-08-02 2007-12-05 Wysoko specyficzny test immunologiczny i zestaw do oznaczania peptydów i białek o znaczeniu biologicznym PL2183599T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07380227A EP2020602A1 (en) 2007-08-02 2007-08-02 High sensitivty immunoassays and kits for the determination of peptides and proteins of biological interest
EP07847829A EP2183599B1 (en) 2007-08-02 2007-12-05 High sensitivty immunoassays and kits for the determination of peptides and proteins of biological interest
PCT/EP2007/063334 WO2009015696A1 (en) 2007-08-02 2007-12-05 High sensitivty immunoassays and kits for the determination of peptides and proteins of biological interest

Publications (1)

Publication Number Publication Date
PL2183599T3 true PL2183599T3 (pl) 2012-04-30

Family

ID=38544110

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07847829T PL2183599T3 (pl) 2007-08-02 2007-12-05 Wysoko specyficzny test immunologiczny i zestaw do oznaczania peptydów i białek o znaczeniu biologicznym

Country Status (23)

Country Link
US (2) US20090035790A1 (pl)
EP (2) EP2020602A1 (pl)
JP (1) JP5657382B2 (pl)
KR (1) KR101461538B1 (pl)
CN (1) CN101861521B (pl)
AR (1) AR064186A1 (pl)
AT (1) ATE533059T1 (pl)
AU (1) AU2007357025B2 (pl)
BR (1) BRPI0721871A2 (pl)
CA (1) CA2689024C (pl)
CL (1) CL2007003513A1 (pl)
CY (1) CY1112553T1 (pl)
DK (1) DK2183599T3 (pl)
ES (1) ES2377151T3 (pl)
HR (1) HRP20120020T1 (pl)
IL (1) IL202598A (pl)
MX (1) MX2009013009A (pl)
PL (1) PL2183599T3 (pl)
PT (1) PT2183599E (pl)
RS (1) RS52124B (pl)
RU (1) RU2461837C2 (pl)
SI (1) SI2183599T1 (pl)
WO (1) WO2009015696A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2478365A1 (en) * 2009-09-18 2012-07-25 Probiodrug AG Novel assay for the detection of amyloid beta peptides
KR101531949B1 (ko) * 2009-12-11 2015-06-26 아라클론 바이오테크, 에스.엘. 아밀로이드 베타 펩티드의 개선된 검출 방법 및 시약
CN102192985A (zh) * 2010-03-18 2011-09-21 上海依科赛生物制品有限公司 一种人体β淀粉样蛋白试剂盒
KR101352670B1 (ko) * 2010-06-15 2014-01-17 울산대학교 산학협력단 알츠하이머 전구단백질 분비 펩타이드의 축적물을 포함하는 뇌 노화 감별 진단 마커
EP2556378B1 (en) * 2010-07-26 2016-05-18 SNU R & DB Foundation Real-time monitoring of depletion of high-abundance blood proteins or recovery of low-abundance blood proteins by uv spectrometry
WO2012054333A2 (en) * 2010-10-20 2012-04-26 Merck Sharp & Dohme Corp. Methods for identifying inhibitors of abeta42 oligomers
EP2511296A1 (en) * 2011-04-12 2012-10-17 Araclón Biotech, S. L. Antibody, kit and method for determination of amyloid peptides
CN103827671B (zh) * 2011-05-03 2017-05-03 联邦科学与工业研究组织 用于检测神经疾病的方法
JP6231263B2 (ja) * 2012-07-17 2017-11-15 株式会社島津製作所 アフィニティ支持体及びそれを用いた物質の捕捉方法
EP3760640A4 (en) * 2018-02-27 2021-11-17 Shimadzu Corporation ANTIBODIES SPECIFICALLY RECOGNIZING THE N-TERMINAL END OF APP669-X, AND METHOD OF IMMUNOLOGICAL ASSAY
CN113884683A (zh) * 2020-07-30 2022-01-04 山东京济生物工程有限公司 一种快速检测Aβ42的双抗体夹心ELISA试剂盒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811310A (en) * 1986-09-30 1998-09-22 Albert Einstein College Of Medicine Of Yeshiva Univ. The Alz-50 monoclonal antibody and diagnostic assay for alzheimer's disease
AU7121191A (en) * 1990-02-26 1991-10-10 Albert Einstein College Of Medicine Of Yeshiva University Diagnostic assay for alzheimer's disease
US7427392B1 (en) * 1994-11-14 2008-09-23 Elan Pharmaceuticals, Inc. Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
US7964192B1 (en) * 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
BR9911291A (pt) * 1998-07-03 2001-12-04 Innogenetics Nv Diagnóstico diferencial de neurodegeneração
JP2004502427A (ja) * 2000-07-06 2004-01-29 フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー 異常アルツハイマー病病理と関連する新規ａｐｐ突然変異
EP1371986A1 (en) * 2002-06-06 2003-12-17 ABETA GmbH Diagnosis of Alzheimer's disease based on the hAbeta42:hAbeta40 ratio
TWI374893B (en) * 2003-05-30 2012-10-21 Janssen Alzheimer Immunotherap Humanized antibodies that recognize beta amyloid peptide
CN101171031B (zh) * 2005-05-05 2011-09-28 默沙东公司 防止和治疗阿尔茨海默病的肽偶联物组合物和方法

Also Published As

Publication number Publication date
AR064186A1 (es) 2009-03-18
CY1112553T1 (el) 2016-02-10
MX2009013009A (es) 2010-03-29
RS52124B (en) 2012-08-31
KR20100046168A (ko) 2010-05-06
JP2010535328A (ja) 2010-11-18
DK2183599T3 (da) 2012-02-27
CL2007003513A1 (es) 2009-02-06
IL202598A0 (en) 2010-06-30
PT2183599E (pt) 2012-02-13
RU2009143671A (ru) 2011-05-27
EP2020602A1 (en) 2009-02-04
CN101861521B (zh) 2014-03-12
CA2689024C (en) 2015-02-24
CA2689024A1 (en) 2009-02-05
US20090035790A1 (en) 2009-02-05
KR101461538B1 (ko) 2014-11-14
RU2461837C2 (ru) 2012-09-20
EP2183599A1 (en) 2010-05-12
JP5657382B2 (ja) 2015-01-21
US20190178899A1 (en) 2019-06-13
IL202598A (en) 2015-10-29
HRP20120020T1 (hr) 2012-03-31
ATE533059T1 (de) 2011-11-15
ES2377151T3 (es) 2012-03-22
AU2007357025B2 (en) 2014-10-23
AU2007357025A1 (en) 2009-02-05
EP2183599B1 (en) 2011-11-09
CN101861521A (zh) 2010-10-13
SI2183599T1 (sl) 2012-03-30
BRPI0721871A2 (pt) 2014-02-18
WO2009015696A1 (en) 2009-02-05

Similar Documents

Publication Publication Date Title
SI2183599T1 (sl) Visoko občutljiv imunološki preskus in komplet za določanje peptidov in proteinov biološkega interesa
EP2102355A4 (en) PROTEINS AND PEPTIDES WITH EXTENDED ACTION AND METHODS OF PRODUCTION AND USE THEREOF
EP1877785A4 (en) METHODS OF MEASURING GLYCANE LEVELS IN PROTEINS
PL1904627T3 (pl) Sposób przygotowania wirusa PRRS i jego białek oraz diagnostycznych zestawów testowych przeznaczonych do jego detekcji
NO344992B1 (no) Anti-GM-CSF antistoffer og anvendelser for disse
CU23869B1 (es) Anticuerpos anti-esclerostina y proteínas funcionales
DE602005012555D1 (de) Künstliches protein zur absoluten quantifizierung von proteinen und verwendungen davon
EP1956372A4 (en) ULTRA-HIGH RESPONSE FOR DETERMINING C REACTIVE PROTEIN AND DETERMINATION METHOD
EP2061884A4 (en) SENSOR PROTEINS AND TEST PROCEDURES THEREFOR
IL186385A0 (en) Antibodies and molecules derived therefrom that bind to 161p2f10b proteins
EP1883816A4 (en) DIAGNOSTIC DEVICE FOR MEASURING THE RELATIONSHIP OF PROTEINS WITH SIMILAR STRUCTURE
IL184343A0 (en) Gitr antibodies for the diagnosis of nsclc
EP2074223A4 (en) TEST PROCEDURE FOR THE DETECTION OF PROTEINS IN THE NATIVE CONDITION AND FOR THE IDENTIFICATION OF THE STABILITY OF PROTEINS IN THE NATIVE CONDITION MODULATING COMPOUNDS
GB2466148B (en) Apparatus and method for determining the results of assays
GB0525541D0 (en) Detection of antibodies
EP2193373A4 (en) METHODS AND KITS FOR MEASURING VON WILLEBRAND FACTOR
BRPI0821597A2 (pt) Métodos para quantificar a quantidade de proteína derivada de plasma e proteína recombinante em uma amostra e para diferenciar proteína derivada de plasma e proteína recombinante em uma amostra, e, kit.
EP1845376A4 (en) QUANTITATIVE MEASURING PROCEDURE FOR RECOMBINANT PROTEIN
EP2047246A4 (en) METHOD AND KITS FOR MEASURING THE LYMPHOCYTE FUNCTION
EP1981704A4 (en) DEVICE AND METHODS FOR PREPARING SAMPLES OF PEPTIDES AND PROTEINS FROM A SOLUTION
DE112004002986A5 (de) Prüfanlage zur zerstörungsfreien Materialprüfung
EP2089532A4 (en) POSITIVE SELECTION OF SERUM PROTEINS FOR PROTEOM ANALYSIS
EP2184605A4 (en) DUAL RECOGNITION IMMUNOASSAY FOR DETECTION OF ANTIBODIES
IL190810A0 (en) Immunoassay method and kit for venom detection
PL2010652T3 (pl) Białko, przeciwciało i pomiar białka